González PA, Ortíz ZMC, Mota VR

Language: English
References: 20
Page: 133-136
PDF size: 47.89 Kb.

ABSTRACT

Title: Serotypes and antimicrobial susceptibility of group B Streptococcus isolated from pregnant women in México Background: Group B streptococci (SGB) are a leading cause of neonatal sepsis and meningitis. Women colonized might also develop pregnancy-associated infections including urinary tract infection, bacteremia and postpartum endometritis. There are nine different capsular types, and with the possibility of a GBS vaccine in the future; it is essential to understand which of these types are circulating. We determined the serotype distribution of isolated rectovaginal and urine GBS obtained from an obstetric population, and also their antibiotic sensitivity patterns. Methods: A total of 101 strains were studied: SGB were confirmed by latex agglutination (Slidex Strepto-Kit bioMérieux), and the serotype was confirmed by latex agglutination (Pastorex Streptococcus B. Becton Dickinson, EUA). Antimicrobial susceptibility testing was performed by a Kirby-Bauer disk diffusion. Results: All SGB were serologically typeable; 61.3% were type I, 25.7% were type II and only 12.8 were type III. All of them were 100% susceptible to beta lactam agents. Only 5.9% strains were resistant to erythromycin. Conclusion: In the last years, no major changes have been observed in the distribution of serotypes of SGB in México, serotype I is still the most common. This makes us think of the possibility of a vaccine that includes serotypes I and II that represent close to 90% of the isolations.

REFERENCES

1. Aitmhand, R., N. Moustaoui, H. Belabbes, N. Elmdaghri and M.Benbachir.2000. Serotypes and antimicrobial susceptibility of group B Streptococcus isolated from neonates in Casablanca. Scand J Infect Dis. 32:339-340.

2. Baker, CJ., and M.S. Edwards.1995. Group B streptococcal infections. P 980-1054 In: J.S. Remington and J.O. Klein (Ed) Infectious disease of the fetus and newborn infant, 4th ed. W.B. Saunders, Philadelphia.

3. Berg, S., B. Trollfors, T. Lagergard, G. Zackrisson and B.A. Claesson.2000. Serotypes and clinical manifestations of group B streptococcal infections in western Sweden. Clin Microbiol Infect. 6:9-13.

4. Bland, M.L., S.T. Vermillion, D.E. Soper and M.Austin.2001. Antibiotic resistance patterns of group B streptococci in late third-trimester rectovaginal cultures. Am J Obstet Gynecol. 184:1125-1126.

5. Collins, T.S., M. Calderon, R.H. Gilman, A. Vivar and P. Charache. 1998. Group B streptococcal colonization in a developing country: its association with sexually transmitted disease and socioeconomic factors. Am. J. Trop. Med. Hyg. 59:633-636.

6. Harrison, L.E., J.A. Elliot, D.M. Dwyer, J.P. Libonati, P. Ferrieri, L. Billman and A. Schuchat. 1998. Serotype distribution of invasive group B Streptococcal isolates in Maryland: Implications for vaccine formulation. J. Infect. Dis. 177:998-1002.

7. Lancefield, R.C. 1933. A serological differentiation of human and other groups of hemolytic streptococci. J. Exp. Med. 57:571-59

8. Morales, J.W., S.S. Dickey, P. Bornick and D.V. Lim. 1999.Change in antibiotic resistance of group B Streptococcus: impact on intrapartum management. Am. J. Obstet. Gynecol. 181: 310-314.

9. Moyo, S.R., J. Mudzori, S.A. Tswana and J.A. Maeland. 2000. Prevalence, capsular type distribution, anthropometric and obstetric factors of group B Streptococcus (Streptococcus agalactiae) colonization in pregnancy. Cent. Afr. J. Med. 46:115-120.

10. Murdoch, D.R. and L.B. Reller. 2001. Antimicrobial susceptibilities of group B streptococci isolated from patients with invasive disease: 10-year perspective. Antimicrob Agents Chemother. 45:3623-3624.

11. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility test. NCCLS document M2 A6. Villanova, Pennsylvania. National Committee for Clinical Laboratory Standards. 1997.

12. Ocampo-Torres, M., H.J. Sánchez –Pérez, A. Nazar-Beutelspacher, A.E. Castro-Ramírez and M.B. Cordero-Ocampo.2000. Factores asociados a la colonización por Streptococcus del grupo B en mujeres embarazadas de los Altos, Chiapas. Salud Pública Mex. 42:413-421.

13. Palacios, G:C., E.K. Eskew, F. Solórzano and S.J. Mattingly.1997. Decreased capacity for type-specific-antigen synthesis accounts for high prevalence of nontypeable strains of group B Streptococci in México. J. Clin. Microbiol. 35:2923-2926.

14. Palacios, G.C., E.K. Eskew, F. Solórzano and S.J. Mattingly.1999. Identification of the high-virulence clone of group B streptococci in Mexican isolates by growth characteristic at 40°C. Current Microbiol. 38:126-131.

15. Pearlman, M.D., C.L. Pierson and R.G. Faix.1998. Frequent resistance of clinical group B streptococci isolates to clindamycin and erythromycin. Obstet. Gynecol. 92:258-261.

16. Ruess, M., U. Muller, A. Sander and R. Berner.2000. Antimicrobial susceptibility patterns of Streptococcus agalactiae in a German University Hospital. Scand. J. Infect. Dis. 32:623-626.

17. Silverman, N.S., M. Morgan and W.S. Nichols. 2000. Antibiotic resistance patterns of group B Streptococcus in antenatal genital cultures. J. Reprod. Med. 45:979-982.

18. Solórzano-Santos, F., G. Echaniz-Avilés, C. Conde-González, E. Calderón-Jaimes, J.L. Arredondo-García and M. Beltrán-Zúñiga.1989. Cervicovaginal infection with group B streptococci among pregnant Mexican women. J. Infect. Dis. 159:1003-1004.

19. Solórzano-Santos, F.R., D. Díaz-Ramos and J.L. Arredondo-García. 1990. Disease caused by group B Streptococcus in México. Pediatr. Infect. Dis. J. 9:66.

20. Ko, W.C., H.C. Lee, L.R. Wang, C.T. Lee, A.J. Liu and J.J. Wu.2001. Serotyping and antimicrobial susceptibility of group B Streptococcus over an eight-year period in southern Taiwan. Eur. J. Clin. Microbiol. Infect. Dis. 20:334-339.